Targeting c-MYC with T-Cells

• Florian Helm,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Thomas Kammertoens,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Frank M. Lehmann,

  Affiliation Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center, Munich, Munich, Germany

  ⨯
• Andrea Wilke,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Heiko Bruns,

  Affiliation Department of Hematology, Oncology, University of Erlangen, Erlangen, Germany

  ⨯
• Josef Mautner,

  Affiliation Department of Pediatrics, Technical University (TU) Munich and Clinical Cooperation Group Pediatric Tumor Immunology, TU Munich and Helmholtz Center, Munich, Germany

  ⨯
• Georg W. Bornkamm,

  Affiliation Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center, Munich, Munich, Germany

  ⨯
• Armin Gerbitz

  * E-mail: armin.gerbitz@uk-erlangen.de

  Affiliation Department of Hematology, Oncology, University of Erlangen, Erlangen, Germany

  ⨯